(Q42537120)

1 November 2017

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice (English)

1 reference

1 November 2017

0 references

Elting LS

1

1 reference

1 November 2017

Rubenstein EB

2

1 reference

1 November 2017

Kurtin D

3

1 reference

1 November 2017

Rolston KV

4

1 reference

1 November 2017

Fangtang J

5

1 reference

1 November 2017

Martin CG

6

1 reference

1 November 2017

Raad II

7

1 reference

1 November 2017

Whimbey EE

8

1 reference

1 November 2017

Manzullo E

9

1 reference

1 November 2017

Bodey GP

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

1 November 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

1 November 2017

83

1 reference

1 November 2017

2597-2607

1 reference

1 November 2017

12

1 reference

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

1 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

The nephrotoxicity of antimicrobial agents (second of three parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Vancomycin therapeutic drug monitoring: is it necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Vancomycin toxicity: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

A prospective study of adverse reactions associated with vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

21 January 2018

Vancomycin: an update

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Vancomycin ototoxicity and nephrotoxicity. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Vancomycin enhancement of experimental tobramycin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

Why monitor peak vancomycin concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2597%3A%3AAID-CNCR27%3E3.0.CO%3B2-L

10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference